Initial oxidation of silver surfaces by S2- and S4+ species von KLEBER, Ch, WIESINGER, R, SCHNÖLLER, J, HILFRICH, U, HUTTER, H, SCHREINER, M

Volltext

In situ QCM and TM-AFM investigations of the early stages of degradation of silver and copper surfaces von KLEBER, Ch, HILFRICH, U, SCHREINER, M

Volltext

Initial oxidation of silver surfaces by Sand S species von Kleber, Ch, Wiesinger, R, Schnoller, J, Hilfrich, U, Hutter, H, Schreiner, M

Volltext

In situ investigations of the interaction of small inorganic acidifying molecules in humidified air with polycrystalline metal surfaces by means of TM-AFM, IRRAS, and QCM von Kleber, Ch, Hilfrich, U., Schreiner, M.

Volltext

TOF-SIMS investigations on weathered silver surfaces von Schnöller, J, Wiesinger, R, Kleber, C, Hilfrich, U, Schreiner, M, Hutter, H

Volltext

Rubidium hydroxide polyethylene glycol crown ether in the conservation of old master paintings von Hilfrich, U., Weser, U.

Volltext

Initial oxidation of silver surfaces by S super(2) super(-)and S super(4) super(+) species von Kleber, Ch, Wiesinger, R, Schnoller, J, Hilfrich, U, Hutter, H, Schreiner, M

Volltext

Initial oxidation of silver surfaces by S 2−and S 4+ species von Kleber, Ch, Wiesinger, R., Schnöller, J., Hilfrich, U., Hutter, H., Schreiner, M.

Volltext

Oxygen-dependent regulation of in vivo replication of simian virus 40 DNA is modulated by glucose von Riedinger, H J, van Betteraey-Nikoleit, M, Hilfrich, U, Eisele, K H, Probst, H

Volltext

Alkali-Ion-Crown Ether in Art and Conservation: The Applied Bioinorganic Chemistry Approach von Hilfrich, Uwe, Taylor, Harold, Weser, Ulrich

Volltext

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial von von Minckwitz, Gunter, Prof, Schneeweiss, Andreas, Prof, Loibl, Sibylle, Prof, Salat, Christoph, MD, Denkert, Carsten, Prof, Rezai, Mahdi, Prof, Blohmer, Jens U, Prof, Jackisch, Christian, Prof, Paepke, Stefan, MD, Gerber, Bernd, Prof, Zahm, Dirk M, MD, Kümmel, Sherko, MD, Eidtmann, Holger, MD, Klare, Peter, MD, Huober, Jens, Prof, Costa, Serban, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Hilfrich, Jörn, Prof, Khandan, Fariba, MD, Fasching, Peter A, Prof, Sinn, Bruno V, MD, Engels, Knut, MD, Mehta, Keyur, MBA, Nekljudova, Valentina, PhD, Untch, Michael, Prof

Volltext

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial von Untch, Michael, Prof, Loibl, Sibylle, MD, Bischoff, Joachim, MD, Eidtmann, Holger, MD, Kaufmann, Manfred, Prof, Blohmer, Jens-Uwe, Prof, Hilfrich, Jörn, Prof, Strumberg, Dirk, Prof, Fasching, Peter A, Prof, Kreienberg, Rolf, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Gerber, Bernd, Prof, Rezai, Mahdi, MD, Jackisch, Christian, Prof, Huober, Jens, Prof, Kühn, Thorsten, Prof, Nekljudova, Valentina, PhD, von Minckwitz, Gunter, Prof

Volltext

Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer von VON MINCKWITZ, Gunter, SCHMITT, Wolfgang D, HILFRICH, Jörn, HUOBER, Jens, FEHM, Tanja, BARINOFF, Jana, RÜDIGER, Thomas, ERBSTOESSER, Erhard, FASCHING, Peter A, KARN, Thomas, MÜLLER, Volkmar, JACKISCH, Christian, LOIBL, Sibylle, DENKERT, Carsten, MÜLLER, Berit M, BLOHMER, Jens U, SINN, Bruno V, EIDTMANN, Holger, EIERMANN, Wolfgang, GERBER, Bernd, TESCH, Hans

Volltext

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial von Denkert, C., Loibl, S., Müller, B.M., Eidtmann, H., Schmitt, W.D., Eiermann, W., Gerber, B., Tesch, H., Hilfrich, J., Huober, J., Fehm, T., Barinoff, J., Jackisch, C., Prinzler, J., Rüdiger, T., Erbstößer, E., Blohmer, J.U., Budczies, J., Mehta, K.M., von Minckwitz, G.

Volltext

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials von Coleman, R, Powles, T, Paterson, A, Gnant, M, Anderson, S, Diel, I, Gralow, J, von Minckwitz, G, Moebus, V, Bergh, J, Pritchard, KI, Bliss, J, Cameron, D, Evans, V, Pan, H, Peto, R, Bradley, R, Gray, R, Bartsch, R, Dubsky, P, Fesl, C, Fohler, H, Greil, R, Jakesz, R, Lang, A, Luschin-Ebengreuth, G, Marth, C, Mlineritsch, B, Samonigg, H, Singer, CF, Steger, GG, Stoger, H, Olivotto, I, Ragaz, J, Christiansen, P, Ejlertsen, B, Ewertz, M, Jensen, MB, Moller, S, Mouridsen, HT, Eiermann, W, Hilfrich, J, Jonat, W, Kaufmann, M, Kreienberg, R, Schumacher, M, Blohmer, JU, Costa, SD, Eidtmann, H, Gerber, B, Jackisch, C, Loibl, S, Dafni, U, Markopoulos, C, Blomqvist, C, Saarto, T, Ahn, JH, Jung, KH, Perrone, F, Bass, G, Brown, A, Bryant, J, Costantino, J, Dignam, J, Fisher, B, Geyer, C, Mamounas, EP, Paik, S, Redmond, C, Swain, S, Wickerham, L, Wolmark, N, Perez, E, Ingle, JN, Suman, VJ, Hadji, P, A'Hern, R, Dowsett, M, Makris, A, Parton, M, Pennert, K, Powles, TJ, Smith, IE, Yarnold, JR, Clack, G, Van Poznak, C, Safra, T, Bell, R, Coleman, RE, Dodwell, D, Hinsley, S, Marshall, HC, Solomayer, E, Fehm, T, Lester, J, Winter, MC, Horsman, JM, Aft, R, Brufsky, AM, Llombart, HA

Volltext

Doxorubicin With Cyclophosphamide Followed by Docetaxel Every 21 Days Compared With Doxorubicin and Docetaxel Every 14 Days As Preoperative Treatment in Operable Breast Cancer: The... von VON MINCKWITZ, Gunter, RAAB, Günter, LAMPE, Dieter, JACKISCH, Christian, DU BOIS, Andreas, KAUFMANN, Manfred, CAPUTO, Angelika, SCHÜTTE, Martin, HILFRICH, Jörn, BLOHMER, Jens U, GERBER, Bernd, COSTA, Serban D, MERKLE, Elisabeth, EIDTMANN, Holger

Volltext

Cytoplasmic Poly(Adenosine Diphosphate–Ribose) Polymerase Expression Is Predictive and Prognostic in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy von VON MINCKWITZ, Gunter, MÜLLER, Berit Maria, DU BOIS, Andreas, ZAHM, Dirk-Michael, KHANDAN, Fariba, HOFFMANN, Gerald, GERBER, Bernd, EIDTMANN, Holger, FEND, Falko, DIETEL, Manfred, MEHTA, Keyur, DENKERT, Carsten, LOIBL, Sibylle, BUDCZIES, Jan, HANUSCH, Claus, DARB-ESFAHANI, Silvia, HILFRICH, Jörn, WEISS, Erich, HUOBER, Jens, UWE BLOHMER, Jens

Volltext

Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) von von Minckwitz, G., Rezai, M., Fasching, P.A., Huober, J., Tesch, H., Bauerfeind, I., Hilfrich, J., Eidtmann, H., Gerber, B., Hanusch, C., Blohmer, J.U., Costa, S.D., Jackisch, C., Paepke, S., Schneeweiss, A., Kümmel, S., Denkert, C., Mehta, K., Loibl, S., Untch, M.

Volltext

Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) stud... von von Minckwitz, G, Rezai, M, Tesch, H, Huober, J, Gerber, B, Zahm, D.M, Hilfrich, J, Costa, S.D, Dubsky, P, Blohmer, J.U, Denkert, C, Hanusch, C, Jackisch, C, Kümmel, S, Fasching, P.A, Schneeweiss, A, Paepke, S, Untch, M, Burchardi, N, Mehta, K, Loibl, S

Volltext

Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial von von Minckwitz, G., Eidtmann, H., Loibl, S., Blohmer, J.-U., Costa, S.-D., Fasching, P.A., Kreienberg, R., Hilfrich, J., Gerber, B., Hanusch, C., Fehm, T., Strumberg, D., Solbach, C., Nekljudova, V., Untch, M.

Volltext